Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Holiday Shopping: St. Jude Adds To A-Fib, Cardio Units With Two Acquisitions

This article was originally published in The Gray Sheet

Executive Summary

St. Jude Medical acquired two privately-held firms just before the New Year for a total of $550 million, gaining tools for artery lesion assessment and precise interventional procedure navigation, among other technologies

You may also be interested in...



Abbott And Coroventis Partner To Address Often-Overlooked Microvascular Dysfunction

Coroventis’ CoroFlow software allows Abbott’s PressureWire X to diagnose coronary microvascular dysfunction caused by invisible blockages in the heart’s smallest arteries.

New Products In Brief

Debuts include DexCom’s G4 Platinum continuous glucose monitor, OraSure’s OraQuick in-home HIV test and St. Jude’s MediGuide 3D navigation system for cardiovascular procedures.

Abbott Can Sell St. Jude’s Intravascular Assessment Tools Under Expanded Alliance

Rights for Abbott to promote and distribute intravascular optical coherence tomography imaging and fractional flow reserve products from St. Jude Medical are added to an existing co-promotion pact between the firms.

Related Content

Topics

Latest News
See All
UsernamePublicRestriction

Register

MT026948

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel